Author: jschoales

When: Thursday, Sept 28, 2023, 12:00 pm -1:00 pm EDT Trial #1: (UHN) PLAN Prevention of persistent pain with Lidocaine infusions in breast cancer surgery Speaker: James Khan, MD, Assistant Professor and Clinician-Scientist, Department of Anesthesia and Pain Medicine, University of Toronto. Trial #2: (CCTG) CRC.10 / NRG-GI008 A phase II/III study to determine chemotherapy recommendations

Read More ->

3CTN is excited to announce that our upcoming Annual Stakeholder Meeting (ASM) & Workshops will be held on October 26-27 2023 in Toronto, please save the date! Registration is now open. Agenda and further details to follow.

Read More ->

The Canadian Cancer Clinical Trials Network (3CTN) is pleased to announce the next impACCT Virtual Rounds Spring Session. When: Tuesday, May 16, 2023 12:00 pm -1:00 pm EDT Trial #1: (UoA) ACIT001 / EXC002 A phase 1b/2 multi-center, de-centralized, dose selection study of autologous CD19-directed chimeric antigen receptor (CAR) T-cells in patients with relapsed/refractory aggressive lymphoma

Read More ->

The Canadian Cancer Clinical Trials Network (3CTN) is pleased to announce the next impACCT Virtual Rounds Winter Session. When: Tuesday, February 7, 2023 12 PM-1 PM EST (UHN) 21-5126 / Peer Navigation pRCTA Web-based Peer Navigation Program for Men with Prostate Cancer: A Hybrid Effectiveness-Implementation TrialSpeaker: Dr. Jacqueline Bender, Princess Margaret Cancer Centre (CCTG) PAC.4 /ECOG-ACRIN EA2185Comparing the

Read More ->